药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aluminium monostearate
Trapidil
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Trapidil.
Aluminium monostearate
Icosapent ethyl
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Icosapent ethyl.
Aluminium monostearate
Triflusal
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Triflusal.
Aluminium monostearate
Tranilast
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Tranilast.
Aluminium monostearate
Cangrelor
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Cangrelor.
Aluminium monostearate
Prasugrel
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Prasugrel.
Aluminium monostearate
Caplacizumab
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Caplacizumab.
Aluminium monostearate
Andrographolide
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Andrographolide.
Aluminium monostearate
Ibudilast
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Ibudilast.
Aluminium monostearate
Beraprost
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Beraprost.
Aluminium monostearate
Defibrotide
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Defibrotide.
Aluminium monostearate
Tesmilifene
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Tesmilifene.
Aluminium monostearate
Resveratrol
The risk or severity of bleeding can be increased when Dexibuprofen is combined with Resveratrol.
Aluminium monostearate
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Dexibuprofen.
Aluminium monostearate
Propacetamol
The risk or severity of adverse effects can be increased when Propacetamol is combined with Dexibuprofen.
Aluminium monostearate
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Dexibuprofen.
Aluminium monostearate
Chenodeoxycholic acid
The metabolism of Dexibuprofen can be decreased when combined with Chenodeoxycholic acid.
Aluminium monostearate
Polymyxin B
The risk or severity of adverse effects can be increased when Dexibuprofen is combined with Polymyxin B.
Aluminium monostearate
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Dexibuprofen.
Aluminium monostearate
Macimorelin
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Dexibuprofen.